Physician profile
Heather M Prater
NPI 1467782508
$781.10
in general payments reported to CMS, 2019-2025
15 companies · $99.85 in 2025
The $99.85 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $31.55 · 2021: $122 · 2023: $168 · 2024: $186 · 2025: $99.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $123.07 | 2023-2025 | Rocklatan, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $91.46 | 2019-2023 | |
| Allergan, INC. | $89.84 | 2019-2021 | |
| Abbvie INC. | $89.72 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $85.96 | 2023-2024 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.65 | 2019 | |
| Aerie Pharmaceuticals, INC. | $58.71 | 2021 | |
| Oyster Point Pharma, INC. | $51.45 | 2023-2024 | Tyrvaya, Ryzumvi |
| Rayner Intraocular Lenses Limited | $31.90 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $18.10 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $16.76 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $16.70 | 2019 | |
| Shire North American Group INC | $15.14 | 2019 | |
| Horizon Therapeutics Plc | $14.96 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.